Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression.

Barbara Seliger, A Höhne, Alexander Knuth, +5

PubMed

HistocompatibilityRenal PathologyImmunologyImmunoeditingPathology +16

The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity

Teresa Hemmerle, Philipp Probst, Leonardo Giovannoni, +3

British Journal of Cancer

Inhibition of Inducible Nitric Oxide Synthase Exacerbates Chronic Cerebral Toxoplasmosis in <i>Toxoplasma gondii</i>-Susceptible C57BL/6 Mice But Does Not Reactivate the Latent Disease in <i>T. gondii</i>-Resistant BALB/c Mice

Dirk Schlüter, M. Deckert‐Schlüter, E Lorenz, +3

The Journal of Immunology

Phase I Study of Sequence-Selective Minor Groove DNA Binding Agent SJG-136 in Patients with Advanced Solid Tumors

Daniel Hochhauser, T Meyer, Victoria J. Spanswick, +8

Clinical Cancer Research

LBA36 Final analysis of RATIONALE-301: Randomized, phase III study of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma

Shukui Qin, Masashi Kudo, T Meyer, +15

Annals of Oncology

HepatologyMedicinePathologyLba36 Final AnalysisMolecular Oncology +8

A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity

Peter I. Joyce, Philip McGoldrick, Rachele A. Saccon, +23

Human Molecular Genetics

Regulation of Microglia by CD4⁺ and CD8⁺ T Cells: Selective Analysis in CD45‐congenic Normal and Toxoplasma gondii‐infected Bone Marrow Chimeras

Dirk Schlüter, T Meyer, Andreas Strack, +5

Brain Pathology

Phenotype and Regulation of Persistent Intracerebral T Cells in Murine <i>Toxoplasma</i> Encephalitis

Dirk Schlüter, T Meyer, Lai‐Yu Kwok, +5

The Journal of Immunology

Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040

Bruno Sangro, Ignacio Melero, Tsz Ching Dorothy Yau, +16

UCL Discovery (University College London)

HepatologyMedicinePathologyLiver DiseaseLiver Cancer +7

Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study

James J. Harding, Tsai‐Sheng Yang, Yen‐Yang Chen, +18

Cancer